CO2022001865A2 - Administración de cannabinoides no inmunogénicos biorremediadores - Google Patents

Administración de cannabinoides no inmunogénicos biorremediadores

Info

Publication number
CO2022001865A2
CO2022001865A2 CONC2022/0001865A CO2022001865A CO2022001865A2 CO 2022001865 A2 CO2022001865 A2 CO 2022001865A2 CO 2022001865 A CO2022001865 A CO 2022001865A CO 2022001865 A2 CO2022001865 A2 CO 2022001865A2
Authority
CO
Colombia
Prior art keywords
immunogenic
cannabinoid
bioremediators
administration
monomer
Prior art date
Application number
CONC2022/0001865A
Other languages
English (en)
Inventor
Michael Flemmens
Original Assignee
Sorse Tech Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorse Tech Corporation filed Critical Sorse Tech Corporation
Publication of CO2022001865A2 publication Critical patent/CO2022001865A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/60—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from the reaction of a mixture of hydroxy carboxylic acids, polycarboxylic acids and polyhydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/123—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds the acids or hydroxy compounds containing carbocyclic rings
    • C08G63/133—Hydroxy compounds containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporciona un método (10) para fabricar un mecanismo de administración de cannabinoides no inmunogénicos biorremediadores. Se combinan un monómero de alcohol y un monómero de ácido (11). Se añaden uno o más cannabinoides (12) a la combinación de monómero de alcohol y monómero de ácido. Un material polimérico de cannabinoides, monómero de alcohol y monómero de ácido (15) se forma y se procesa para convertirse en un producto para inserción, inyección o aplicación tópica por parte de un usuario.
CONC2022/0001865A 2019-08-23 2022-02-22 Administración de cannabinoides no inmunogénicos biorremediadores CO2022001865A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962891179P 2019-08-23 2019-08-23
PCT/US2020/047673 WO2021041335A1 (en) 2019-08-23 2020-08-24 Bio-remedial non-immunogenic cannabinoid delivery
US17/001,250 US20210052494A1 (en) 2019-08-23 2020-08-24 Bio-remedial non-immunogenic cannabinoid delivery

Publications (1)

Publication Number Publication Date
CO2022001865A2 true CO2022001865A2 (es) 2022-07-08

Family

ID=74645627

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0001865A CO2022001865A2 (es) 2019-08-23 2022-02-22 Administración de cannabinoides no inmunogénicos biorremediadores

Country Status (5)

Country Link
US (1) US20210052494A1 (es)
CO (1) CO2022001865A2 (es)
CR (1) CR20220081A (es)
MX (1) MX2022002288A (es)
WO (1) WO2021041335A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4135687A4 (en) * 2020-04-17 2024-04-17 University of Connecticut POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015184313A1 (en) 2014-05-30 2015-12-03 Secant Medical, Inc. Water-mediated preparations of polymeric materials
US20170042791A1 (en) * 2015-08-11 2017-02-16 KannaInnovations LLC Topical compositions comprising hydroxy acids and cannabinoids for skin care
US20180263954A1 (en) * 2016-09-27 2018-09-20 CannTab Therapeutics, Limited Sustained Release Cannabinoid Formulations
AU2018233582B2 (en) * 2017-03-16 2022-04-07 CannTab Therapeutics, Limited Modified release multi-layer tablet cannabinoid formulations
EP3652234B1 (en) * 2017-07-11 2021-04-14 The Secant Group, LLC Poly(glycerol sebacate)-interleukin inhibitor copolymers and methods of making
EP3755436A1 (en) * 2018-02-21 2020-12-30 The Secant Group, LLC Dermocosmetic compositions including glycerol-sebacate

Also Published As

Publication number Publication date
CR20220081A (es) 2022-07-14
US20210052494A1 (en) 2021-02-25
MX2022002288A (es) 2022-06-08
WO2021041335A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
BR112017027813A2 (pt) conjugados de agente de ligação-droga (adcs) e conjugados de agente de ligação-pró-droga (apdcs) tendo grupos enzimaticamente cliváveis
MX2023009205A (es) Conjugados de ligando-farmaco (adcs) con grupos escindibles enzimaticamente.
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
CO2022001865A2 (es) Administración de cannabinoides no inmunogénicos biorremediadores
MX2019001552A (es) Composicion curable fotocromatica, uso de la misma y monomeros de polirotaxano.
BR112015017246A2 (pt) formulação farmacêutica que compreende um corticosteroide insolúvel e um corticosteroide solúvel
PH12019500126A1 (en) Topical formulation for promoting wound healing
MX2019006345A (es) Proceso para preparar microcapsulas de tamaño controlado que comprenden una etapa de fotopolimerizacion.
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
WO2017220042A3 (zh) 氨力农的药物组合物及其在高血压治疗中的应用
MX2018002337A (es) Moleculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas.
WO2015200514A3 (en) Biphenyl amides with modified ether groups as hsp90 inhibitors and hsp70 inducers
ZA202006535B (en) Pharmaceutical composition comprising salbutamol
AR119043A1 (es) Métodos para acelerar la cicatrización mediante el uso de composiciones cannabinoides
RS52695B (en) PHARMACEUTICAL DEPOSIT CONTAINING N- {5 - [(CYCLOPROPYLAMINO) CARBONYL] -2-METHYLPHENYL} -3-FLUORO-4- (PIRIDIN-2-ILMETOXY) BENZAMIDE
WO2017220044A3 (zh) 联苯苄唑的药物组合物及其保肝作用
BR112018008769A2 (pt) formulações farmacêuticas, formulações líquidas aquosa reconstituída e liofilizada, seringa, método de fabricação de uma formulação farmacêutica, método para tratamento de uma doença e uso de uma formulação reconstruída
FR2957256B1 (fr) Composition cosmetique avec alcanes lineaires volatils et copolymeres d'alcenes
AU2018324111A1 (en) Viscous composition for treating ischemia
BR112014009805A2 (pt) composição aquosa de revestimento arquitetônico inseticida e processo para produzir a composição
WO2017210527A8 (en) Autotaxin inhibitors
FR3074687B1 (fr) Nouveaux alkyl polyrhamnosides, procede pour leur preparation et composition cosmetiques et/ou pharmaceutiques en comprenant
MX2017001900A (es) Composicion nasal con capacidades de formacion de pelicula.
UA132534U (uk) Спосіб виготовлення насіннєво-органо-мінеральних гранул для висіву дрібнонасіннєвих лісотехнічних культур
US20200306280A1 (en) Enhancing medicinal properties of Hemp, Cannabis, and Cannabidiol (“CBD”) with Rhamnolipid